肌少症与晚发性阿尔茨海默痴呆、轻度认知障碍及认知衰退的相关性
研究纳入1175名非痴呆老年人,每年用17项认知测试评估,基于生物电阻抗测肌肉量和握力构建肌少症复合评分,随访平均5.6年。结果显示基线肌少症越重,阿尔茨海默痴呆和轻度认知障碍风险越高、认知衰退越快;肌肉功能而非瘦肌肉量驱动该关联。
要点
- 基线肌少症越重,阿尔茨海默痴呆风险越高(HR 1.50)。
- 基线肌少症越重,轻度认知障碍风险越高(HR 1.21)。
- 肌肉功能而非瘦肌肉量与认知结局相关。
核心结论
- 肌肉功能差而非瘦肌肉量减少驱动肌少症与晚发性认知障碍的关联。
研究设计与样本
- 对1175名非痴呆老年人每年用17项认知测试评估,基于生物电阻抗测肌肉量和握力构建肌少症复合评分,随访平均5.6年。
主要发现
- 基线肌少症越重,阿尔茨海默痴呆风险越高(HR 1.50,95%CI 1.20-1.86,p<0.001)。
- 基线肌少症越重,轻度认知障碍风险越高(HR 1.21,95%CI 1.01-1.45,p=0.04)。
- 基线肌少症越重,认知衰退速度越快(估计值-0.013,p=0.01)。
- 肌肉功能与阿尔茨海默痴呆、轻度认知障碍和认知衰退相关,无论模型是否纳入瘦肌肉量。
- 瘦肌肉量在模型纳入肌肉功能后与认知障碍或认知衰退无关。
临床怎么用
- 在老年认知风险评估中可关注肌肉功能(如握力)而非仅测肌肉量。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We examined whether sarcopenia is associated with the occurrence of late-life cognitive impairment. METHODS: Nondemented older adults (N = 1175) underwent annual testing with 17 cognitive tests summarized as a global cognitive score. A composite sarcopenia score was constructed based on muscle mass measured with bioelectrical impedance and muscle function based on grip strength. Cox proportional hazard models were employed to examine associations of sarcopenia with incident Alzheimer's dementia (AD) and incident mild cognitive impairment (MCI). Linear mixed-effect models determined the association of sarcopenia with cognitive decline. All models controlled for age, sex, education, race, and height squared. RESULTS: Average follow-up was 5.6 years. More severe sarcopenia at baseline was associated with a higher risk of incident AD (hazard ratio [HR], 1.50 [95% confidence interval 1.20-1.86]; p < 0.001) and of MCI (1.21 [1.01-1.45]; 0.04) and a faster rate of cognitive decline (estimate = -0.013; p = 0.01). Analyses of the individual components of sarcopenia showed that muscle function was associated with incident AD, incident MCI, and cognitive decline with and without a term for lean muscle mass in the model. In contrast, lean muscle mass was not associated with incident cognitive impairment or cognitive decline when a term for muscle function was included in the model. CONCLUSIONS: Poor muscle function, but not reduced lean muscle mass, drives the association of sarcopenia with late-life cognitive impairment. Further work is needed to identify features of muscle structure, which may increase the specificity of sarcopenia for identifying older adults at risk for late-life cognitive impairment.
引用
- Beeri MS, Leugrans SE, Delbono O, et al. Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline. J Am Geriatr Soc. 2021. PMID: 33954985. doi:10.1111/jgs.17206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。